Novel CXC-chemokine antagonists

Details for Australian Patent Application No. 2006310573 (hide)

Owner Merck Serono SA

Inventors Power, Christine; Proudfoot, Amanda

Agent Griffith Hack

Pub. Number AU-B-2006310573

PCT Pub. Number WO2007/051781

Priority 60/733,547 04.11.05 US; 05110205.1 31.10.05 EP

Filing date 30 October 2006

Wipo publication date 10 May 2007

Acceptance publication date 19 January 2012

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/90 (2006.01) Mutation or genetic engineering

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/051781 Priority application(s): WO2007/051781

30 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

19 January 2012 Application Accepted

  Published as AU-B-2006310573

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006310577-Use of SDF-1 for the treatment and/or prevention of neurological diseases

2006310566-Process for the preparation of sterile powdered pharmaceutical compounds